Hijacked medical data is now more valuable to cybercriminals than stolen credit card numbers. About 10 times more valuable. It's been very well known that medical devices, along with other industrial devices that are on separate networks managed by the manufacture and controlled by a government agency, have been prone to attack," Greg Enriquez, CEO of cybersecurity company TrapX (San Mateo, California), told Medical Device Daily.
The medical device and consumer electronics worlds continue to link up, a trend illustrated by a new partnership between Medtronic (Dublin, Ireland) and Samsung (Seoul, South Korea). At the American Diabetes Association (ADA; Alexandria, Virginia) meeting in Boston, Medtronic unveiled these plans for a range of diabetes solutions.
Medigus (Omer, Israel), a company that develops minimally invasive endosurgical tools, recently listed and began trading American depositary receipts (ADRs) on the Nasdaq Capital Market (NASDAQ: MDGS). The Bank of New York Mellon is serving as depositary for the ADRs and each ADR represents 100 ordinary shares of the company.
A company trying to bring a new weight loss device to the U.S. said it completed enrollment in its multi-center U.S. pivotal trial in just 62 days. The website the company set up to recruit participants attracted 24,000 inquiries from patients wanting to enroll in the SMART trial. The FDA granted Obalon Therapeutics (Carlsbad, California) an investigational device exemption to run the trial at 15 U.S. sites only four months ago.
Just two months after raising $55.5 million in a private financing round, Natera (San Carlos, California) filed IPO paperwork with the SEC that could bring in as much as $100 million in an initial public offering. Natera makes DNA-based genetic tests. The company has developed its technology for prenatal testing and is also developing blood-based diagnostics for cancer.
A company named after the fastest land animal in the world is making notable strides in the hemodynamic monitoring space. Cheetah Medical (Newton, Massachusetts) has stretched its product line to include the Starling SV, a non-invasive hemodynamic monitoring system designed to provide data for real-time clinical decision making in the hospital setting. The Starling SV has already been cleared by the FDA and has a CE mark.
